Stada Joins Effort To Void Takeda's ADHD Drug IP In UK
Stada has asked a London court to annull Takeda's extended patent protections over ADHD drug Elvanse, echoing Aristo's claim that the U.K. supplementary protection certificate covering the drug is invalid....To view the full article, register now.
Already a subscriber? Click here to view full article